Showing results (571-580 of 604) with videos related to

Sort By:
Pageof 61
Arthritis Research & Therapy|January 12, 2021
Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosusYirong Xiang, Mengtao Li, Hui Luo, et al.
Annals of the Rheumatic Diseases|May 1, 2020
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient managementMarco Matucci-Cerinic, Cosimo Bruni, Yannick Allanore, et al.
Journal of the American Academy of Dermatology|July 13, 2025
The Prospective Registry Of MyositIS (PROMIS): II. Temporal shifts in causes of death among patients with idiopathic inflammatory myopathiesChen Yu, Chanyuan Wu, Shangyi Jin, et al.
Therapeutic Advances in Chronic Disease|July 28, 2022
Risk assessment in systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort studyQian Wang, Junyan Qian, Mengtao Li, et al.
The New England Journal of Medicine|August 30, 2013
Macitentan and morbidity and mortality in pulmonary arterial hypertensionTomás Pulido, Igor Adzerikho, Richard N Channick, et al.
Signal Transduction and Targeted Therapy|November 25, 2025
Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trialJiuliang Zhao, Changsong Lin, Qibing Xie, et al.
Med (New York, N.Y.)|July 11, 2024
Phenotypic subgroup in serologically active clinically quiescent systemic lupus erythematosus: A cluster analysis based on CSTAR cohortYufang Ding, Yangzhong Zhou, Feng Zhan, et al.
Frontiers in Medicine|March 22, 2021
Validation of the REVEAL Prognostic Models in Systemic Lupus Erythematosus-Associated Pulmonary Arterial HypertensionJingge Qu, Mengtao Li, Xiaofeng Zeng, et al.
The European Respiratory Journal|July 4, 2020
Pulmonary arterial hypertension associated with primary Sjögren's syndrome: a multicentre cohort study from ChinaJieying Wang, Mengtao Li, Qian Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2021
Predicting the Risk of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: A Chinese Systemic Lupus Erythematosus Treatment and Research Group Cohort StudyJingge Qu, Mengtao Li, Yanhong Wang, et al.
Pageof 61